US Patent Issued to DIGNITY HEALTH on July 1 for "Inhibitory interneuron treatment methods, uses and compositions for diabetes" (Arizona Inventor)

ALEXANDRIA, Va., July 3 -- United States Patent no. 12,343,359, issued on July 1, was assigned to DIGNITY HEALTH (San Francisco).

"Inhibitory interneuron treatment methods, uses and compositions for diabetes" was invented by Zaman Mirzadeh (Phoenix).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are compositions, methods of treatment, and uses of inhibitory interneuron precursors, derived from the brain's medial ganglionic eminence, or differentiated from iPSC or ESCs, for the treatment of pre-diabetes or diabetes. In some embodiments, compositions including inhibitory interneuron precursors are transplanted into the arcuate nucleus of the hypothalamus region of the brain, to treat, for examp...